Success Stories: EB-1A Approved for Fellow in Minnesota in the Field of Hepatology

Client’s Testimonial:

 

Thanks for helping with the I-140 approval.[…] I'll be happy to refer you to my friends.
 


On July 31st, 2014, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Fellow in the Field of Hepatology (Approval Notice)


General Field: Hepatology

Position at the Time of Case Filing: Fellow

Country of Origin: India

Service CenterNebraska Service Center (NSC)

State of Residence at the Time of Filing:  Minnesota

Approval Notice Date: July 31, 2014

Processing Time: 5 months, 28 days

 

 


Case Summary:

In this case, the client that we had the opportunity to work with was a Fellow from India the field of Hepatology. She had conducted her research in the highly specialized areas of both elucidating the underlying biological causes of hepatobiliary malignancies like hepatocellular carcinoma (HCC) and hepatitis C, and comprehensively evaluating different treatment strategies for those diseases. Her work had resulted in 17 peer-reviewed scientific articles, 2 book chapters, 1 book and numerous presentations at national and international conferences; at the time that her case was filed, her publications had been cited at least 187 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of her work.  She had also reviewed 5 manuscripts for distinctive, internationally-circulated journals.  Her superior level of expertise was confirmed in the following quote from an independent recommender, Her research thus far has shown that mice that have been genetically modified to express greater amounts of Sulfl are more likely to develop HCC. Thus, Sulfl expression has been identified as a brand new drug target for HCC treatment, which is as significant as any of [Client’s] past findings.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that she sought to remain in the United States to continue work in the area of Hepatology, and that her continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, her case was approved in 5 months and 28 days.